These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10329067)

  • 1. Circulating N-terminal pro-atrial natriuretic peptide is an independent predictor of left ventricular hypertrophy in the general population. The Tromsø Study.
    Schirmer H; Omland T
    Eur Heart J; 1999 May; 20(10):755-63. PubMed ID: 10329067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-terminal atrial natriuretic peptide and left ventricular geometry and function in a population sample of elderly males.
    Arnlöv J; Lind L; Stridsberg M; Andrén B; Lithell H
    J Intern Med; 2000 Jun; 247(6):699-708. PubMed ID: 10886492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy.
    Yamamoto K; Burnett JC; Jougasaki M; Nishimura RA; Bailey KR; Saito Y; Nakao K; Redfield MM
    Hypertension; 1996 Dec; 28(6):988-94. PubMed ID: 8952587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study.
    Vasan RS; Benjamin EJ; Larson MG; Leip EP; Wang TJ; Wilson PW; Levy D
    JAMA; 2002 Sep; 288(10):1252-9. PubMed ID: 12215132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic potential of cardiac natriuretic peptides in dialysis patients.
    Mallamaci F; Zoccali C; Tripepi G; Benedetto FA; Parlongo S; Cataliotti A; Cutrupi S; Giacone G; Bellanuova I; Stancanelli B; Malatino LS;
    Kidney Int; 2001 Apr; 59(4):1559-66. PubMed ID: 11260421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of atrial natriuretic peptide B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction.
    Davidson NC; Naas AA; Hanson JK; Kennedy NS; Coutie WJ; Struthers AD
    Am J Cardiol; 1996 Apr; 77(10):828-31. PubMed ID: 8623734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma B-type natriuretic peptide reflects left ventricular hypertrophy and diastolic function in hypertension.
    Uusimaa P; Tokola H; Ylitalo A; Vuolteenaho O; Ruskoaho H; Risteli J; Linnaluoto M; Peuhkurinen K;
    Int J Cardiol; 2004 Nov; 97(2):251-6. PubMed ID: 15458692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of arginine vasopressin with low atrial natriuretic peptide levels, left ventricular remodelling, and outcomes in adults with and without heart failure.
    Chirinos JA; Sardana M; Oldland G; Ansari B; Lee J; Hussain A; Mustafa A; Akers SR; Wei W; Lakatta EG; Fedorova OV
    ESC Heart Fail; 2018 Oct; 5(5):911-919. PubMed ID: 29969536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natriuretic peptides in patients with aortic stenosis.
    Qi W; Mathisen P; Kjekshus J; Simonsen S; Bjørnerheim R; Endresen K; Hall C
    Am Heart J; 2001 Oct; 142(4):725-32. PubMed ID: 11579366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial and brain natriuretic peptide and endothelin-1 concentration in patients with idiopathic arterial hypertension: the dependence on the selected morphological parameters.
    Irzmański R; Banach M; Piechota M; Kowalski J; Barylski M; Cierniewski C; Pawlicki L
    Clin Exp Hypertens; 2007 Apr; 29(3):149-64. PubMed ID: 17497342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between left ventricular mass and the resting and post-exercise release of ANP in healthy men.
    Pawlicki L; Irzmański R; Rózalski S; Kowalski J; Kokot F
    Med Sci Monit; 2001; 7(5):903-7. PubMed ID: 11535932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reference ranges for natriuretic peptides for diagnostic use are dependent on age, gender and heart rate.
    Loke I; Squire IB; Davies JE; Ng LL
    Eur J Heart Fail; 2003 Oct; 5(5):599-606. PubMed ID: 14607197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction.
    Lerman A; Gibbons RJ; Rodeheffer RJ; Bailey KR; McKinley LJ; Heublein DM; Burnett JC
    Lancet; 1993 May; 341(8853):1105-9. PubMed ID: 8097801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Plasma levels of atrial and brain natriuretic peptide and left ventricular geometry in patients with essential hypertension].
    Kosmala W; Spring A
    Pol Merkur Lekarski; 2003 Mar; 14(81):216-9. PubMed ID: 12914098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BNP and ANP as diagnostic and predictive markers in heart failure with left ventricular systolic dysfunction.
    Falcão LM; Pinto F; Ravara L; van Zwieten PA
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):121-9. PubMed ID: 15526247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender-specific differences of cardiac remodeling in subjects with left ventricular dysfunction: a population-based study.
    Luchner A; Bröckel U; Muscholl M; Hense HW; Döring A; Riegger GA; Schunkert H
    Cardiovasc Res; 2002 Feb; 53(3):720-7. PubMed ID: 11861042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic performance of mid-regional portion of pro-atrial natriuretic peptide for the detection of left ventricular hypertrophy in Caucasian hypertensive patients.
    Bhandari SS; Davies JE; Struck J; Ng LL
    J Hum Hypertens; 2012 Dec; 26(12):711-5. PubMed ID: 22113442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between atrial natriuretic peptides, echocardiographic findings and mortality in an elderly population sample.
    Iivanainen AM; Tikkanen I; Tilvis R; Heikkilá J; Helenius T; Kupari M
    J Intern Med; 1997 Apr; 241(4):261-8. PubMed ID: 9159597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-terminal proatrial natriuretic peptide correlates with systolic dysfunction and left ventricular filling pattern in patients with idiopathic dilated cardiomyopathy.
    Fruhwald FM; Fahrleitner A; Watzinger N; Dobnig H; Schumacher M; Maier R; Zweiker R; Leb G; Klein W
    Heart; 1999 Nov; 82(5):630-3. PubMed ID: 10525523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concentration of natriuretic peptides in patients suffering from idiopathic arterial hypertension and left ventricular diastolic dysfunction confirmed by echocardiography.
    Irzmański R; Pawlicki L; Charłusz M; Kowalski J
    Clin Exp Hypertens; 2012; 34(7):530-40. PubMed ID: 22783987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.